STAT1 and cancer: Monocyte derivatives control tissue microenvironments in tumors and in chronic inflammatory diseases [68–70] and inhibitors of monocyte signaling have been applied in cancer [70] and in PAH where STAT1 inhibition is effective in preventing PAH [71].